142 related articles for article (PubMed ID: 37349884)
1. Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1.
Li X; Li H; Shao MM; Miao J; Fu Y; Hu B
Thorac Cancer; 2023 Aug; 14(22):2093-2104. PubMed ID: 37349884
[TBL] [Abstract][Full Text] [Related]
2. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
3. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.
Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX
Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
5. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
6. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
7. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
9. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible lipid droplet-associated (HILPDA) facilitates the malignant phenotype of lung adenocarcinoma cells in vitro through modulating cell cycle pathways.
Sheng Y; Li J; Yang Y; Lu Y
Tissue Cell; 2021 Jun; 70():101495. PubMed ID: 33535136
[TBL] [Abstract][Full Text] [Related]
11. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
12. Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells.
Li SQ; Feng J; Yang M; Ai XP; He M; Liu F
J Nat Med; 2020 Sep; 74(4):777-787. PubMed ID: 32666278
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
[TBL] [Abstract][Full Text] [Related]
14. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.
Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632
[TBL] [Abstract][Full Text] [Related]
15. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma.
Chen C; Liu H; Li Y; Xu Q; Liu J
BMC Cancer; 2024 Jan; 24(1):63. PubMed ID: 38216925
[TBL] [Abstract][Full Text] [Related]
17.
Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J
Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788
[TBL] [Abstract][Full Text] [Related]
18. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
[TBL] [Abstract][Full Text] [Related]
19. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
20. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
